Non-Exclusive License

A non-exclusive patent license grants limited rights to practice a patent without foreclosing the same rights to others: NON-EXCLUSIVE LICENSE: the licensee receives the right to make, use, sell (or the specific rights granted); the licensor retains the right to grant the same or similar licenses to any other party; the licensor may also practice the patent itself; EXCLUSIVE LICENSE: the licensee receives the right to practice the patent; the licensor agrees NOT to grant the same rights to any third party; the licensee has market exclusivity (within the licensed field/territory); SOLE LICENSE: a hybrid between exclusive and non-exclusive; the licensor agrees not to grant additional licenses to third parties but retains the right to practice the patent itself; PRACTICAL IMPLICATIONS: non-exclusive: licensor maximizes royalty revenue by licensing multiple competitors; licensee has no exclusivity advantage but pays lower royalty rates; exclusive: licensee gains competitive advantage; typically pays higher royalty rate or lump sum; often tied to performance obligations; WHAT DETERMINES THE STRUCTURE: technology maturity: non-exclusive for widely adopted technology; exclusive for early-stage or highly differentiated technology; competitive dynamics: if the licensee is one of many in a market, non-exclusive is common; if the licensee needs exclusivity for its business model (pharma: FDA approval), exclusive is necessary; patent owner goals: maximize revenue (non-exclusive to many) vs. maximize value of one deal (exclusive to one); OWNERSHIP vs. LICENSE: an exclusive licensee with all substantial rights may have standing to sue for infringement independently (Speedplay v. Bebop, Fed. Cir. 2000); a non-exclusive licensee typically does NOT have standing to sue for infringement without joining the patent owner.

Pricing a non-exclusive license requires balancing the value of access against the value of exclusivity: VALUE OF EXCLUSIVITY PREMIUM: an exclusive licensee pays a premium for the competitive advantage of exclusivity; the exclusivity premium reflects: the incremental value of being the only party with access to the technology; the competitive harm from having a competitor with the same license; the licensor's opportunity cost of foregoing multiple licensees; NON-EXCLUSIVE ROYALTY RATE: typically lower than equivalent exclusive rate; rational: the non-exclusive licensee does not capture the full economic value of the patent (competitors have the same access); typical discount: non-exclusive rates are 25-50% lower than exclusive rates for comparable technology; FACTORS THAT REDUCE THE DISCOUNT: if all competitors will seek licenses anyway (FRAND-committed patents; widely adopted standards), non-exclusive is the de facto exclusive because competitors are equally constrained; if the licensee has a first-mover advantage even without formal exclusivity; if the technology is difficult to license (few willing licensees), each licensee has quasi-exclusivity by default; FACTORS THAT INCREASE THE DISCOUNT: if multiple direct competitors will obtain the same license; if design-around alternatives are available; if the licensor's licensing program will result in full market saturation of non-exclusive licensees; MOST-FAVORED-LICENSEE (MFL) PROTECTION: non-exclusive licensees often seek MFL clauses: if the licensor grants a better rate to any subsequent licensee, the MFL clause entitles the first licensee to the same rate; MFL clauses reduce the risk that a non-exclusive licensee is undercut by later, better-priced deals.

Sublicense rights in a non-exclusive license depend entirely on whether the license grants them: DEFAULT RULE: a bare patent license (no specific sublicense grant) does NOT include the right to sublicense; a licensee cannot grant to others what it does not hold; sublicense rights must be EXPRESSLY GRANTED in the license agreement; TYPICAL SUBLICENSE STRUCTURES: (a) NO SUBLICENSE RIGHT: common in standard patent licenses; licensee may only practice for itself; if the licensee sells a product containing the patented technology, the purchaser's right is governed by exhaustion, not sublicense; (b) LIMITED SUBLICENSE RIGHT: licensee may grant sublicenses only to affiliates (subsidiaries and parent companies); or only within a specific field of use; or only to customers who use the product (not competitors); (c) BROAD SUBLICENSE RIGHT: licensee may grant sublicenses to any third party; sublicensees are bound by the terms of the original license; licensor receives a percentage of sublicensee royalties; PATENT EXHAUSTION vs. SUBLICENSE: important distinction: when a licensee sells a product embodying a patented invention, the purchaser acquires exhaustion-based rights — the right to use and sell the specific item purchased; this is NOT the same as a sublicense; exhaustion arises from the authorized sale; sublicense is a grant of independent patent rights; SUBLICENSEE OBLIGATIONS: sublicensees are typically bound by: royalty obligations (flowing through to licensor); field of use and territory restrictions; audit rights; most sublicense agreements include a flow-down of all material obligations; LICENSOR APPROVAL: some non-exclusive licenses require licensor consent before any sublicense can be granted; or provide licensor with right of first refusal to license sublicensee directly.

Patent exhaustion is a doctrine that terminates the patent owner's rights in a specific item after its first authorized sale: THE EXHAUSTION DOCTRINE: Quanta Computer v. LG Electronics (S.Ct. 2008): an authorized sale of a patented item exhausts the patent owner's right to control further use or sale of that specific item; WHAT TRIGGERS EXHAUSTION: an authorized sale (or other disposition) by the patent owner or a licensee authorized to sell; the item must substantially embody the patent (Quanta: even a component that substantially embodies the patented combination can exhaust); WHAT EXHAUSTION PREVENTS: the patent owner (or licensor) cannot use the patent to restrict the downstream purchaser's use or resale of the specific purchased item; this is why a purchaser of a licensed product does not need a patent license to use or resell it; EXHAUSTION vs. SUBLICENSE: a customer buying a product from a non-exclusive licensee gains EXHAUSTION rights (to use and resell that specific item); the customer does NOT get a patent license to make additional copies of the patented product; NON-EXCLUSIVE LICENSE AND EXHAUSTION INTERACTION: a product manufactured and sold under a valid non-exclusive license exhausts the patent owner's claims against downstream purchasers; the license must authorize the specific sale that triggers exhaustion; a license limited to manufacturing (no right to sell) does NOT exhaust claims against distributors; GEOGRAPHIC EXHAUSTION: US: post-Impression Products v. Lexmark (S.Ct. 2017): even international sales by the patent owner exhaust US patent rights; earlier Mallinckrodt restricted exhaustion for sales with explicit restrictions — overruled; CONDITIONAL SALES: after Lexmark: patent owners cannot impose post-sale restrictions via the patent (licensing-style restrictions after authorized sale are not enforceable via patent law); other legal theories (contract, trade secret) may still apply.

Most-favored-licensee (MFL) clauses are protective provisions that ensure a non-exclusive licensee is not commercially disadvantaged by better terms given to competitors: HOW MFL WORKS: the licensor agrees that if it grants a subsequent license to any other licensee at terms more favorable than those in the current license, the current licensee automatically receives those more favorable terms; WHAT MFL COVERS (TYPICALLY): royalty rate; royalty base definition; upfront fees; field of use (if applicable); WHAT MFL TYPICALLY EXCLUDES: settlement licenses: licenses granted to resolve or avoid litigation often include below-market rates reflecting litigation risk; without a settlement carve-out, the settlement license could trigger MFL rights; government licenses (compulsory licenses); charity/academic licenses at reduced rates; licenses in different fields of use or territories; TIME LIMITS: some MFL clauses expire after a period (e.g., 5 years) or after a certain number of licensees have been signed; MFL clauses with no time limit create a permanent ratchet downward on royalty rates; LICENSOR RISK FROM MFL: the licensor must carefully track all licenses; a better rate granted to a subsequent licensee automatically applies to all MFL-protected licenses; under-priced subsequent deals become the benchmark; FRAND CONNECTION: for standard-essential patents, the FRAND non-discrimination obligation is effectively an MFL requirement for all similarly situated licensees; MFL clauses in SEP licenses operationalize this non-discrimination requirement; DISPUTE OVER COMPARABILITY: what is a 'more favorable' rate? If the rate is lower but the field of use is broader, is it more favorable?; parties often negotiate definitions of what constitutes a comparable license for MFL trigger purposes; STRATEGIC USE: non-exclusive licensees should always seek MFL protection in competitive markets where the licensor will continue to sign competitors.